INSYS DEVELOPMENT COMPANY, INC.
19Patents
19Active
19Granted
47Portfolio score
Filing activity: Oct 4, 2012 → May 24, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10039710B2 | Epinephrine spray formulations | Human Necessities | 23 | Active |
| US9642848B2 | Sublingual naloxone spray | Human Necessities | 16 | Active |
| US9345771B2 | Oral cannabinoid formulations | Human Necessities | 14 | Active |
| US9839611B2 | Sublingual buprenorphine spray | Human Necessities | 5 | Active |
| US9918981B2 | Liquid buprenorphine formulations | Human Necessities | 4 | Active |
| US9289387B2 | Method of treating pain by administering sublingual fentanyl spray | Human Necessities | 3 | Active |
| US9642844B2 | Sublingual fentanyl spray | Human Necessities | 2 | Active |
| US9370518B2 | Sildenafil sublingual spray formulation | Human Necessities | 2 | Active |
| US10265309B2 | Sublingual opioid formulations containing naloxone | Human Necessities | 1 | Active |
| US9662334B2 | Sildenafil sublingual spray formulations | Human Necessities | 1 | Active |
| US10265293B2 | Oral cannabinoid formulations | Human Necessities | 1 | Active |
| US9855234B2 | Diclofenac sublingual spray | Human Necessities | 0 | Active |
| US10016403B2 | Sublingual fentanyl spray | Human Necessities | 0 | Active |
| US9867818B2 | Sublingual buprenorphine spray | Human Necessities | 0 | Active |
| US10111833B2 | Sildenafil sublingual spray formulations | Human Necessities | 0 | Active |
| US10414578B2 | Actuator for a package and method of use | Human Necessities | 0 | Active |
| US10172833B2 | Sublingual ondansetron spray | Human Necessities | 0 | Active |
| US9642797B2 | Sublingual fentanyl spray and methods of use to treat pain | Human Necessities | 0 | Active |
| US9566233B2 | Ondansetron sublingual spray formulation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.